| Stanley M Hochberg, MD | |
|
Med Ventive, 1 Kendall Sq Bldg 200, Cambridge, MA 02139 | |
| (617) 374-8505 | |
| Not Available |
| Full Name | Stanley M Hochberg |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | Med Ventive, Cambridge, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396871984 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 59129 (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Stanley M Hochberg, MD 14 Chestnut St, Winchester, MA 01890-3019 Ph: (617) 374-8505 | Stanley M Hochberg, MD Med Ventive, 1 Kendall Sq Bldg 200, Cambridge, MA 02139 Ph: (617) 374-8505 |
News Archive
MicroTransponder, Inc., a privately-held medical device company, has just announced a $7 Million Series B round of funding. MicroTransponder is developing a wireless neurostimulation platform for the treatment of chronic pain and other neurological indications.
Perfluorocarbons, a class of inert, oily polymers, have a proven track record in a variety of clinical uses, including in contrast-enhanced ultrasound imaging and in eye surgery to correct a detached retina.
A new study shows that alcohol abuse is by far the worst habit to have when compared to other recreational drugs like crack or heroin. Neuropharmacologist David Nutt, of Imperial College London who is also a former British government drug advisor and his team rated 20 different drugs on a scale that takes into account the various harms caused by a drug. Drugs are rated on the nine harms a drug causes to an individual and seven harms a drug causes to the society. The scale was developed by a panel of experts called the Independent Scientific Committee on Drugs (ICSD), ranges from 0 (no harm) to 100 (greatest possible harm). It is weighted so that a drug that scores 50 is half as harmful as a drug that scores 100.
InNexus Biotechnology Inc. has announced the United States Food & Drug Administration (FDA) has completed its comprehensive review of the development plans for InNexus' lead preclinical candidate, DXL625 (CD20) for the prospective treatment of Non-Hodgkin's Lymphoma (NHL) and/or Chronic Lymphocytic Leukemia (CLL).
› Verified 4 days ago
Katherine E Miller, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 119 Windsor St, Cambridge, MA 02139 Phone: 617-665-3370 | |
Md Sheikh, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2067 Massachusetts Ave, Cambridge, MA 02140 Phone: 617-575-5550 | |
Randy F Wertheimer, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1493 Cambridge St, 1320 Macht Bldg, Cambridge, MA 02139 Phone: 617-665-1117 | |
Rachid Chakri, PA-C Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 Binney St, Cambridge, MA 02142 Phone: 617-903-5000 | |
Alexandra B. Houck, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 75 Mount Auburn St, Cambridge, MA 02138 Phone: 617-495-8414 Fax: 617-496-0560 | |
Elizabeth Grace Rocco, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 355 Main St, Cambridge, MA 02142 Phone: 617-903-5000 | |
Sherry A. Graham, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 822 Somerville Ave, Cambridge, MA 02140 Phone: 617-903-5000 |